Provided by Tiger Trade Technology Pte. Ltd.

Outlook Therapeutics, Inc.

0.5705
-0.0195-3.31%
Volume:1.28M
Turnover:739.29K
Market Cap:138.63M
PE:-0.76
High:0.5898
Open:0.5800
Low:0.5700
Close:0.5900
52wk High:2.54
52wk Low:0.1611
Shares:243.00M
Float Shares:198.00M
Volume Ratio:0.70
T/O Rate:0.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7479
EPS(LYR):-1.7940
ROE:-3.65%
ROA:-143.17%
PB:-13.34
PE(LYR):-0.32

Loading ...

Nov 23, 2022

Major Issues Report

8-K - Current report
Aug 15, 2022

Major Issues Report

8-K - Current report
Aug 10, 2022

Major Issues Report

8-K - Current report
Aug 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 08, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jul 07, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 17, 2022

Major Issues Report

8-K - Current report
Jun 07, 2022

Major Issues Report

8-K - Current report
May 31, 2022

Major Issues Report

8-K - Current report
May 13, 2022

Major Issues Report

8-K - Current report
May 13, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 22, 2022

Major Issues Report

8-K - Current report
Apr 22, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 01, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 31, 2022

Major Issues Report

8-K - Current report
Mar 25, 2022

Major Issues Report

8-K - Current report
Feb 16, 2022

Delisting

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Feb 15, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]